Pityriasis rubra pilaris with preceding cytomegalovirus infection

Dermatology

Volumn 219, Issue 4, 2009, Pages 350-352

  Kawara, Shigeru ^a   Miyake, Muneharu ^a   Oiso, Naoki ^a   Kawada, Akira ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cytomegalovirus infection; Etiology; Pityriasis rubra pilaris

Indexed keywords

COLECALCIFEROL; CYTOMEGALOVIRUS ANTIBODY; ETRETINATE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREDNISOLONE; PSORALEN;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL ASSESSMENT; CLINICAL FEATURE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE DURATION; ERYTHEMA; ERYTHRODERMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPANESE; MIXED CONNECTIVE TISSUE DISEASE; NONHUMAN; PAPULE; PITYRIASIS RUBRA PILARIS; PRIORITY JOURNAL; SERODIAGNOSIS; SKIN BIOPSY; ULTRAVIOLET A RADIATION;

ADULT; BIOPSY; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; PITYRIASIS RUBRA PILARIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 72449196639     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000240018     Document Type: Article

References (16)

1. Judge MR, McLean WHI, Munro CS: Pityriasis rubra pilaris; in Burns T, Breathnach S, Cox N, Griffiths C (eds): Rook's Textbook of Dermatology, ed 7. Oxford, Blackwell Science, 2004, pp 34.64-34.69.
2. Albert MR, Mackool BT: Pityriasis rubra pilaris. Int J Dermatol 1999; 38: 1-11.
3. Sehgal VN, Srivastava G: (Juvenile) Pityriasis rubra pilaris. Int J Dermatol 2006; 45: 438-446.
4. Drago F, Aragone MG, Lugani C, Rebora A: Cytomegalovirus infection in normal and immunocompromised humans. Dermatology 2000; 200: 189-195.
5. Gelmetti C, Schiuma AA, Cerri D, Gianotti F: Pityriasis rubra pilaris in childhood: A long-term study of 29 cases. Pediatr Dermatol 1986; 3: 446-451.
6. Larrègue M, Champion R, Bressieux JM, Laidet B, Lorette G: Le pityriasis rubra pilaris aigu de l'enfant. Ann Dermatol Venereol 1983; 110: 221-228.
7. Sørensen KB, Thestrup-Pedersen K: Pityriasis rubra pilaris: A retrospective analysis of patients. Acta Derm Venereol 1999; 79: 405-406.
8. Möhrenschlager M, Abeck D: Further clinical evidence for involvement of bacterial superantigens in juvenile pityriasis rubra pilaris (PRP): Report of two new cases. Pediatr Dermatol 2002; 19: 569.
9. Betlloch I, Ramón R, Silvestre JF, Carnero L, Albares MP, Bañuls J: Acute juvenile pityriasis rubra pilaris: A superantigen mediated disease? Pediatr Dermatol 2001; 18: 411-414.
10. Klein A, Szeimies R-M, Landthaler M, Karrer S: Exacerbation of pityriasis rubra pilaris under efalizumab therapy. Dermatology 2007; 215: 72-75.
11. Yang FC, Jessup C, Dahiya M, Reynolds R: Pityriasis rubra pilaris exacerbation with topical use of imiquimod. Int J Dermatol 2008; 47: 1076-1078.
12. De D, Dogra S, Narang T, Radotra BD, Kanwar AJ: Pityriasis rubra pilaris in a HIV-positive patient. Skinmed 2008; 7: 47-50.
13. Blasdale C, Turner RJ, Leonard N, Ong ELC, Lawrence CM: Spontaneous clinical improvement in HIV-associated follicular syndrome. Clin Exp Dermatol 2004; 29: 480-482.
14. Lipsker D, Saurat J-H: A new concept: Paraviral eruptions. Dermatology 2005; 211: 309-311.
15. Chan H, Liu FT, Naguwa S: A review of pityriasis rubra pilaris and rheumatologic associations. Clin Dev Immunol 2004; 11: 57-60.
16. Müller H, Gattringer C, Zelger B, Höpfl R, Eisendle K: Infliximab monotherapy as firstline treatment for adult-onset pityriasis rubra pilaris: Case report and review of the literature on biologic therapy. J Am Acad Dermatol 2008; 59:S65-S70.